In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens

Manual of Clinical Microbiology.

Annals of Internal Medicine · 1970 · 1.3K citations

Life Sciences, Infectious Diseases, Microbiology +17

In vitro activity of the new fluoroquinolone CP-99,219

Harold C. Neu, N X Chin · Antimicrobial Agents and Chemotherapy · 1994 · 94 citations

Life Sciences, Microbiology, Antimicrobial Pharmacology +9

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

Agnès Girard, D Girard, Thomas D. Gootz et al. · Antimicrobial Agents and Chemotherapy · 1995 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219)

Robert A. Wise, D. Mortiboy, Jenny Child et al. · Antimicrobial Agents and Chemotherapy · 1996 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

Maria Paris, Sheila Hickey, Mónica Trujillo et al. · Antimicrobial Agents and Chemotherapy · 1995 · 48 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14